Alembic Pharmaceuticals (BOM:533573) EV-to-Revenue : 3.05 (As of May. 28, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Alembic Pharmaceuticals EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Alembic Pharmaceuticals's enterprise value is ₹189,666 Mil. Alembic Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₹62,286 Mil. Therefore, Alembic Pharmaceuticals's EV-to-Revenue for today is 3.05.

The historical rank and industry rank for Alembic Pharmaceuticals's EV-to-Revenue or its related term are showing as below:

BOM:533573' s EV-to-Revenue Range Over the Past 10 Years
Min: 1.63 Med: 3.19 Max: 7
Current: 3.05

During the past 13 years, the highest EV-to-Revenue of Alembic Pharmaceuticals was 7.00. The lowest was 1.63. And the median was 3.19.

BOM:533573's EV-to-Revenue is ranked worse than
60.61% of 1023 companies
in the Drug Manufacturers industry
Industry Median: 2.29 vs BOM:533573: 3.05

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-28), Alembic Pharmaceuticals's stock price is ₹946.30. Alembic Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹317.00. Therefore, Alembic Pharmaceuticals's PS Ratio for today is 2.99.

Alembic Pharmaceuticals EV-to-Revenue Historical Data

The historical data trend for Alembic Pharmaceuticals's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alembic Pharmaceuticals EV-to-Revenue Chart

Alembic Pharmaceuticals Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

EV-to-Revenue

Get a 7-Day Free Trial

2.62

3.64

2.91

1.84

3.16

Alembic Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															1.84	2.13	2.69	2.44	3.16

Competitive Comparison of Alembic Pharmaceuticals's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Alembic Pharmaceuticals's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alembic Pharmaceuticals's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alembic Pharmaceuticals's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Alembic Pharmaceuticals's EV-to-Revenue falls into.

Alembic Pharmaceuticals EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Alembic Pharmaceuticals's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	189665.884	/	62286.3
	=	3.05

Alembic Pharmaceuticals's current Enterprise Value is ₹189,666 Mil.
Alembic Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹62,286 Mil.

Alembic Pharmaceuticals (BOM:533573) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Alembic Pharmaceuticals's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	946.30	/	316.999
	=	2.99

Alembic Pharmaceuticals's share price for today is ₹946.30.
Alembic Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹317.00.

Alembic Pharmaceuticals EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Alembic Pharmaceuticals's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Alembic Pharmaceuticals (BOM:533573) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alembic Pharmaceuticals Ltd (BOM:533573) » Definitions » EV-to-Revenue

Traded in Other Exchanges

APLLTD:India

Address

Alembic Road, Vadodara, GJ, IND, 390 003

Website

https://www.alembicpharmaceuticals.com

Alembic Pharmaceuticals Ltd is a specialty and generic drug manufacturing company. The company focuses on manufacturing and marketing generic pharmaceutical products across the globe. Alembic also operates a branded formulation business that covers a range of therapeutic areas such as dermatology, oncology, ophthalmology, and injectable formulations. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Alembic Pharmaceuticals (BOM:533573) Headlines

No Headlines